Venmax Drugs & Pharmaceuticals Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 225982,
    "name": "Venmax Drugs",
    "stock_name": "Venmax Drugs",
    "full_name": "Venmax Drugs & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/venmax-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.99",
    "chg": 0.99,
    "chgp": "3.41%",
    "dir": 1,
    "prev_price": "29.00",
    "mcapval": "16.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531015,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE154G01022",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "201 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venmax-drugs-225982-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Venmax Drugs?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-venmax-drugs-3695032",
        "imagepath": "",
        "date": "2025-11-13 00:04:45",
        "description": "Answer:\nThe historical performance of Venmax Drugs shows significant fluctuations in its financial metrics over the years, particularly in net sales, operating profit, and overall profitability.\n\nBreakdown:\nVenmax Drugs reported net sales of 0.81 Cr in March 2025, a notable increase from 0.00 Cr in March 2024, but still below the 2.55 Cr recorded in March 2015. The total operating income followed a similar trend, reaching 0.81 Cr in March 2025, compared to 0.00 Cr in the previous year. However, total expenditure surged to 1.86 Cr in March 2025, up from 0.10 Cr in March 2024, leading to an operating profit (PBDIT) of 0.00 Cr in March 2025, a decline from 0.10 Cr in March 2024. The profit before tax was slightly negative at -0.01 Cr in March 2025, contrasting with a profit of 0.09 Cr in March 2024. Consequently, the profit after tax also fell to -0.01 Cr in March 2025 from 0.06 Cr in March 2024. The company's..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3667603",
        "imagepath": "",
        "date": "2025-11-03 21:22:40",
        "description": "As of 03-Nov, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 28.70, reflecting a change of 0.7 or 2.5% upward. The stock has shown strong performance recently, gaining 10.09% over the last three days and outperforming its sector by 1.2% today. Additionally, over the past month, the stock has surged by 42.43%, significantly outpacing the Sensex, which has only increased by 3.41%. However, it is important to note that there has been a notable decline in investor participation, with delivery volume dropping by 77.96% against the five-day average, which may indicate a potential concern regarding sustained interest in the stock.\n\nIn the broader market context, Venmax Drugs has outperformed the Sensex over the past week, with a return of 1.59% compared to the benchmark's decline of 0.94%. Year-to-date, the stock has also significantly outperformed the Sensex, achieving a return ..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3653463",
        "imagepath": "",
        "date": "2025-10-28 23:45:51",
        "description": "As of 28-Oct, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 27.88, reflecting a decrease of 0.37, or 1.31%. The stock has been underperforming its sector, with a performance today that is down by 1.05%. It has experienced consecutive declines over the last two days, resulting in a total drop of 6.16%. Despite this recent downturn, the stock has shown strong performance over the past month, with a return of 25.93%, and a year-to-date increase of 54.55%. Additionally, Venmax is trading above its moving averages across various time frames, indicating a generally positive trend prior to the recent falls. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Venmax's short-term performance over the past week has outpaced the benchmark Sensex, which has only increased by 0.24%, while Venmax has r..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3644644",
        "imagepath": "",
        "date": "2025-10-24 21:28:51",
        "description": "As of 24-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 29.71, reflecting a rise of Rs 1.31 or 4.61%. The stock has shown strong performance, gaining 48.85% over the last nine days and outperforming its sector by 5% today. It opened with a 5% gain and reached an intraday high of Rs 29.82. Additionally, the stock is trading above its moving averages across various time frames, indicating a bullish trend. The recent increase in delivery volume, which rose by 69.77% against the five-day average, suggests rising investor participation, contributing positively to the stock's momentum. There are no positive or negative factors explicitly mentioned that could impact the stock's recent movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has only increased by 0.31% over the past week, Venmax Drugs has significantly outperformed with ..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3629549",
        "imagepath": "",
        "date": "2025-10-17 21:17:18",
        "description": "As of 17-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 25.44, reflecting a rise of 1.21 or 4.99%. The stock has shown strong performance, gaining 27.45% over the past week and 5.78% over the last month. It has outperformed its sector by 4.52% today and has been on a consecutive gain streak for the last five days. However, there has been a notable decline in investor participation, with delivery volume dropping by 86.46% against the five-day average, which could indicate a potential concern for future trading activity. The stock's moving averages are higher than the 5-day and 20-day averages but lower than the longer-term averages, suggesting mixed signals regarding its momentum.\n\nBroader market context shows that while Venmax has significantly outperformed the Sensex with a year-to-date return of 41.02% compared to the Sensex's 7.44%, the overall mark..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3623503",
        "imagepath": "",
        "date": "2025-10-15 21:17:14",
        "description": "As of 15-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 23.08, reflecting a rise of 1.09 or 4.96%. The stock has shown strong performance recently, gaining 15.63% over the last three days and outperforming its sector by 4.88% today. Despite this positive momentum, the stock has seen a decline of 11.40% over the past month. Additionally, the stock's delivery volume has decreased by 34.6% compared to the 5-day average, indicating a potential drop in investor participation. The stock is currently trading above its 5-day moving averages but below its longer-term moving averages, suggesting mixed signals regarding its trend.\n\nBroader market context indicates that while Venmax has outperformed the Sensex by a significant margin of 21.41% over the past week, the benchmark index has only increased by 1.02% during the same period. Year-to-date, Venmax has also ..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3615677",
        "imagepath": "",
        "date": "2025-10-13 21:11:03",
        "description": "As of 13-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 20.95, which reflects a change of 0.99 or 4.96% upward. The stock has shown a strong performance today, outperforming its sector by 5.11%. Notably, there has been a significant rise in investor participation, with delivery volume increasing by 119.92% against the 5-day average. While the stock is currently higher than its 5-day moving averages, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 8.89%, contrasting with a decline of 23.43% over the past month, indicating a recent recovery phase.\n\nIn the broader market context, the Sensex has only increased by 0.66% over the past week, highlighting that Venmax's short-term return is significantly stronger than the benchmark. Year-to-date, Venmax has outperformed the Sensex, with a return of 16.13%..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3595841",
        "imagepath": "",
        "date": "2025-10-06 21:10:19",
        "description": "As of 06-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 19.22, reflecting a decrease of 0.93 or 4.62%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 9.13% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's delivery volume has also significantly decreased, with an 88.63% drop compared to the 5-day average, suggesting falling investor participation. There is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nBroader market context shows that Venmax Drugs has underperformed against the benchmark Sensex, which has gained 1.77% over the past week while Venmax has declined by 13.58%. In the last month, the stock has dropped ..."
      },
      {
        "title": "Why is Venmax Drugs falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venmax-drugs-fallingrising-3574935",
        "imagepath": "",
        "date": "2025-09-26 21:05:37",
        "description": "As of 26-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 22.10, which represents a decrease of Rs 1.14 or 4.91%. The stock has underperformed its sector by 2.57% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 7.57% during this period. The stock opened significantly lower today, with a loss of 4.99%, and has traded below its moving averages across various time frames. Additionally, the stock's performance over the past week and month shows a steep decline of 16.29% and 36.13%, respectively, indicating a challenging period for the company. There is no information available regarding positive or negative factors affecting the stock.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has decreased by 2.66% over the past week and 0.45% over the past month, Venmax Drugs' performance ..."
      }
    ],
    "total": 73,
    "sid": "225982",
    "stock_news_url": "https://www.marketsmojo.com/news/venmax-drugs-pharmaceuticals-225982"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "25-Nov-2025",
      "details": "The board has considered and accepted the Resignation of Mrs . Dakshita Jain as Non Executive Independent Director of the company w.e.f. November 24 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Resignation of Director",
      "datetime": "24-Nov-2025",
      "details": "The Board has considered and accepted the resignation of Mrs. Dakshita Jain as Non Executive Independent Director of the Company w.e.f. November 24 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Nov-2025",
      "details": "Newspaper Publication of unaudited financials results for the Quarter and Half Year ended September 30 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Venmax Drugs?

2025-11-13 00:04:45

Answer: The historical performance of Venmax Drugs shows significant fluctuations in its financial metrics over the years, particularly in net sales, operating profit, and overall profitability. Breakdown: Venmax Drugs reported net sales of 0.81 Cr in March 2025, a notable increase from 0.00 Cr in March 2024, but still below the 2.55 Cr recorded in March 2015. The total operating income followed a similar trend, reaching 0.81 Cr in March 2025, compared to 0.00 Cr in the previous year. However, total expenditure surged to 1.86 Cr in March 2025, up from 0.10 Cr in March 2024, leading to an operating profit (PBDIT) of 0.00 Cr in March 2025, a decline from 0.10 Cr in March 2024. The profit before tax was slightly negative at -0.01 Cr in March 2025, contrasting with a profit of 0.09 Cr in March 2024. Consequently, the profit after tax also fell to -0.01 Cr in March 2025 from 0.06 Cr in March 2024. The company's...

Why is Venmax Drugs falling/rising?

2025-11-03 21:22:40

As of 03-Nov, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 28.70, reflecting a change of 0.7 or 2.5% upward. The stock has shown strong performance recently, gaining 10.09% over the last three days and outperforming its sector by 1.2% today. Additionally, over the past month, the stock has surged by 42.43%, significantly outpacing the Sensex, which has only increased by 3.41%. However, it is important to note that there has been a notable decline in investor participation, with delivery volume dropping by 77.96% against the five-day average, which may indicate a potential concern regarding sustained interest in the stock. In the broader market context, Venmax Drugs has outperformed the Sensex over the past week, with a return of 1.59% compared to the benchmark's decline of 0.94%. Year-to-date, the stock has also significantly outperformed the Sensex, achieving a return ...

Why is Venmax Drugs falling/rising?

2025-10-28 23:45:51

As of 28-Oct, Venmax Drugs & Pharmaceuticals Ltd is currently priced at 27.88, reflecting a decrease of 0.37, or 1.31%. The stock has been underperforming its sector, with a performance today that is down by 1.05%. It has experienced consecutive declines over the last two days, resulting in a total drop of 6.16%. Despite this recent downturn, the stock has shown strong performance over the past month, with a return of 25.93%, and a year-to-date increase of 54.55%. Additionally, Venmax is trading above its moving averages across various time frames, indicating a generally positive trend prior to the recent falls. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Venmax's short-term performance over the past week has outpaced the benchmark Sensex, which has only increased by 0.24%, while Venmax has r...

Why is Venmax Drugs falling/rising?

2025-10-24 21:28:51

As of 24-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 29.71, reflecting a rise of Rs 1.31 or 4.61%. The stock has shown strong performance, gaining 48.85% over the last nine days and outperforming its sector by 5% today. It opened with a 5% gain and reached an intraday high of Rs 29.82. Additionally, the stock is trading above its moving averages across various time frames, indicating a bullish trend. The recent increase in delivery volume, which rose by 69.77% against the five-day average, suggests rising investor participation, contributing positively to the stock's momentum. There are no positive or negative factors explicitly mentioned that could impact the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has only increased by 0.31% over the past week, Venmax Drugs has significantly outperformed with ...

Why is Venmax Drugs falling/rising?

2025-10-17 21:17:18

As of 17-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 25.44, reflecting a rise of 1.21 or 4.99%. The stock has shown strong performance, gaining 27.45% over the past week and 5.78% over the last month. It has outperformed its sector by 4.52% today and has been on a consecutive gain streak for the last five days. However, there has been a notable decline in investor participation, with delivery volume dropping by 86.46% against the five-day average, which could indicate a potential concern for future trading activity. The stock's moving averages are higher than the 5-day and 20-day averages but lower than the longer-term averages, suggesting mixed signals regarding its momentum. Broader market context shows that while Venmax has significantly outperformed the Sensex with a year-to-date return of 41.02% compared to the Sensex's 7.44%, the overall mark...

Why is Venmax Drugs falling/rising?

2025-10-15 21:17:14

As of 15-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 23.08, reflecting a rise of 1.09 or 4.96%. The stock has shown strong performance recently, gaining 15.63% over the last three days and outperforming its sector by 4.88% today. Despite this positive momentum, the stock has seen a decline of 11.40% over the past month. Additionally, the stock's delivery volume has decreased by 34.6% compared to the 5-day average, indicating a potential drop in investor participation. The stock is currently trading above its 5-day moving averages but below its longer-term moving averages, suggesting mixed signals regarding its trend. Broader market context indicates that while Venmax has outperformed the Sensex by a significant margin of 21.41% over the past week, the benchmark index has only increased by 1.02% during the same period. Year-to-date, Venmax has also ...

Why is Venmax Drugs falling/rising?

2025-10-13 21:11:03

As of 13-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 20.95, which reflects a change of 0.99 or 4.96% upward. The stock has shown a strong performance today, outperforming its sector by 5.11%. Notably, there has been a significant rise in investor participation, with delivery volume increasing by 119.92% against the 5-day average. While the stock is currently higher than its 5-day moving averages, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 8.89%, contrasting with a decline of 23.43% over the past month, indicating a recent recovery phase. In the broader market context, the Sensex has only increased by 0.66% over the past week, highlighting that Venmax's short-term return is significantly stronger than the benchmark. Year-to-date, Venmax has outperformed the Sensex, with a return of 16.13%...

Why is Venmax Drugs falling/rising?

2025-10-06 21:10:19

As of 06-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 19.22, reflecting a decrease of 0.93 or 4.62%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 9.13% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock's delivery volume has also significantly decreased, with an 88.63% drop compared to the 5-day average, suggesting falling investor participation. There is no information available regarding positive or negative factors that could influence the stock's recent movement. Broader market context shows that Venmax Drugs has underperformed against the benchmark Sensex, which has gained 1.77% over the past week while Venmax has declined by 13.58%. In the last month, the stock has dropped ...

Why is Venmax Drugs falling/rising?

2025-09-26 21:05:37

As of 26-Sep, Venmax Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 22.10, which represents a decrease of Rs 1.14 or 4.91%. The stock has underperformed its sector by 2.57% today and has been on a consecutive downward trend for the last two days, resulting in a total decline of 7.57% during this period. The stock opened significantly lower today, with a loss of 4.99%, and has traded below its moving averages across various time frames. Additionally, the stock's performance over the past week and month shows a steep decline of 16.29% and 36.13%, respectively, indicating a challenging period for the company. There is no information available regarding positive or negative factors affecting the stock. Broader Market Context: In comparison to the benchmark Sensex, which has decreased by 2.66% over the past week and 0.45% over the past month, Venmax Drugs' performance ...

View All News